Purchase Order HHSN272201301054P
Award Date 9/12/13
Potential Completion Date 10/12/13
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of the "EasySep Negative Human NK, 1 mL" product, which is a cell separation system used in stem cell research, immunology, and infectious...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,605 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of Human Cell Enrichment Kits. This contract did not have a set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops specialized biological materials,...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...
- This is a firm fixed-price purchase order awarded to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The contract is for the delivery of specialized cell culture kits, including the STEMDIFF MICROGLIA DIFFERENTIATION KIT, STEMDIFF MICROGLIA MATURATION KIT, and STEMDIFF HEMATOPOETIC...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,350.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a foreign-owned, for-profit organization, for the provision of human cell enrichment kits. The contract has a completion date of May 31, 2019 and was awarded on May 15, 2018. This contract is not set aside for any specific business type. Stemcell Technologies Inc. is a...
- This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...
- This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS). The $24,536.00 firm fixed-price purchase order is for the provision of the AMBIS 1787964 QUOTE Q-921198 item, which is described as the "EASY STEP NEGATIVE HUMAN CD4 KIT". The award does not have a small business set-aside designation. Stemcell...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,645.00 Firm Fixed Price Purchase Order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the provision of HUMAN CD8 KITS. This award was not set aside for any specific business category. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops cell culture media, cell separation...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Stemcell Technologies Inc. The contract, valued at $13,005.00, is for the provision of INTESTICULT OGM HUMAN (AMBIS #2218293) research materials. Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies, is a key supplier of specialized biological materials, laboratory supplies,...